Recently, phenotypical and functional analysis unraveled that the expansion of DN B cells in SLE patients is attributable to a sub-phenotype denominated DN2, which lacks the homing receptor CXCR5 and the complement receptor CD21, but expresses the integrin subunit CD11c (8). The gene discussed is CXCR5; the disease is systemic lupus erythematosus.